Transformation of medicine therapies developing innovative and pioneering drugs.
Ctra. de Valldemossa Km. 7,4. ParcBIT. Edificio 17. 2º C-8 - Palma de Mallorca
EPM Joining Date
Founders Pablo V. Escribá, Vicenç Tur
Investors email contact
Continuous investment in Drug research and development (R&D) with high quality standards.
On the Road to BME Growth
- 23/07/2020 - Registered Advisor
- 29/09/2020 - Transformation in PLC
|(thousand of Euros)||2019||2020||2021*||2022*|
|Net business turnover||450||144,86||200||200|
|Average number of employees||09||19||21||27|
License and supply to Big pharmas worldwide, under a B2B exploitation model
Development of oncological drugs as a new-generation of “First in class medicines” based on the innovative technology called MLT (Membrane lipid therapy), strongly patented worldwide. Our therapeutic platform uses highly safe therapeutic lipid molecules to improve the quality of life of people affected by some incurable diseases.
Medicines innovation in the best interest of mankind